142P Quality-adjusted survival with ribociclib plus fulvestrant (R+F) versus placebo plus fulvestrant (P+F) in postmenopausal women (PMW) HR+/HER2- advanced breast cancer (ABC) based on the MONALEESA-3 trial
Title:
142P Quality-adjusted survival with ribociclib plus fulvestrant (R+F) versus placebo plus fulvestrant (P+F) in postmenopausal women (PMW) HR+/HER2- advanced breast cancer (ABC) based on the MONALEESA-3 trial
Author:
Jerusalem, G. Delea, T. Martin Jimenez, M. De Laurentiis, M. Nusch, A. Beck, J.T. Chan, A. Im, S-A. Neven, P. Lonshteyn, A. Chandiwana, D. Lanoue, B. Fasching, P.